Japan Tissue Engineering Co., Ltd. (J-TEC) | Creating a Future for Regenerative Medicine

Nov. 25, 2021News Release

Announcement of Start of Clinical Trial for Allogeneic Cultured Epidermis “Allo-JaCE03”

- J-TEC’s first allogeneic cell therapy product: Submitted notification of clinical trial plan to realize ready-made product that can be swiftly provided to patients -
Nov. 22, 2021Columns / Topics

Are you interested in regenerative medicine?
Nov. 12, 2021Columns / Topics

Tales of Regenerative Medicine Vol.4 - Vol. 5
Nov. 1, 2021Columns / Topics

The Thought That Has Run Through My Experience With Regenerative Medicine
Oct. 29, 2021Financial

Released Financial Report for the 2nd Quarter of FY2021

Columns & Topics

Nov. 22, 2021[INSIDE REGENERATIVE MEDICINE]

Are you interested in regenerative medicine?

Nov. 12, 2021[PICK UP]

Tales of Regenerative Medicine Vol.4 - Vol. 5

Nov. 1, 2021[INSIDE REGENERATIVE MEDICINE]

The Thought That Has Run Through My Experience With Regenerative Medicine

Jul. 2, 2021[PICK UP]

Tales of Regenerative Medicine Vol.3 - Differentiation - each cell has a defined role

Apr. 1, 2021[PICK UP]

Tales of Regenerative Medicine Vol.2 - Cells - the building blocks of our body

Apr. 1, 2021[PICK UP]

Tales of Regenerative Medicine Vol.1 - Our body's ability to regenerate

For
Patients and their Families

Regenerative Medicine
Developers

Cultured Human
Tissue Users